Sano Chemicals, Inc. is a pioneering pharmaceutical company based in Bryan, TX, dedicated to developing innovative solutions for acute and chronic illnesses. With a focus on groundbreaking research, their lead asset, Occidiofungin, offers a first-in-class treatment option for serious fungal infections, including recurrent vulvovaginal candidiasis and systemic fungal infections in immunocompromised patients.
Additionally, Sano Chemicals addresses the growing concern of antibiotic resistance with their second asset, Mutacin. This therapeutic compound provides a new solution to systemic bacterial infections, including those caused by MRSA, aiming to reduce mortality and morbidity associated with emerging antibiotic-resistant infections. With a strong emphasis on scientific advancement, Sano Chemicals is at the forefront of developing effective treatments for challenging medical conditions.
Generated from the website
